On February 6, vaccine development and manufacturing specialist EuBiologics announced that it had participated in the 'Korea 100-Day Mission' tabletop exercise to assess global cooperation mechanisms for rapid vaccine development and supply in the event of the next pandemic.


YubioLogics, a company specializing in vaccine development and manufacturing, participated in the 'Korea 100-Day Mission' tabletop exercise to assess global cooperation mechanisms for the rapid development and supply of vaccines in the event of the next pandemic. YubioLogics

YubioLogics, a company specializing in vaccine development and manufacturing, participated in the 'Korea 100-Day Mission' tabletop exercise to assess global cooperation mechanisms for the rapid development and supply of vaccines in the event of the next pandemic. YubioLogics

View original image

This tabletop exercise was jointly promoted by the Ministry of Food and Drug Safety and the Korea Disease Control and Prevention Agency, and was led by the Coalition for Epidemic Preparedness Innovations (CEPI). Domestic and overseas health institutions, including the International Vaccine Institute (IVI), as well as private companies, also took part.


The 100-Day Mission is a global health security cooperation initiative that aims to secure the capacity to develop and supply key response tools such as vaccines, therapeutics, and diagnostic technologies within 100 days after the emergence of a new infectious disease.


EuBiologics participated in this tabletop exercise as a private vaccine development and manufacturing company, reviewing its capabilities in vaccine production and supply during a pandemic and its role within the global cooperation framework. The exercise assumed the occurrence of a hypothetical new infectious disease and was conducted in a way that examined the full-cycle response system, from initial response and pathogen acquisition to vaccine development, clinical trials, regulatory approval, production, and supply.



A representative from EuBiologics said, "Effective pandemic response is only possible when international cooperation is in place alongside robust capabilities for stable vaccine supply," adding, "Based on our experience in supplying vaccines for global public health, we will continue to prepare so that we can contribute to rapid and stable vaccine supply even in infectious disease crisis situations."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing